Comparative analysis of the content of biochemical markers of endothelial dysfunction in women with preeclampsia and in the development of vascular retinal pathology
Year: 2020, volume 16 Issue: №2 Pages: 668-671
Heading: Ophtalmology Article type: Original article
Authors: Fil А.А., Sorokin E.L., Kolenko O.V.
Organization: Far Eastern Federal University, Postgraduate Institute for Public Health Workers, S. Fyodorov Eye Microsurgery Federal State Institution
Heading: Ophtalmology Article type: Original article
Authors: Fil А.А., Sorokin E.L., Kolenko O.V.
Organization: Far Eastern Federal University, Postgraduate Institute for Public Health Workers, S. Fyodorov Eye Microsurgery Federal State Institution
Summary:
Purpose: to study the level of markers of endothelial dysfunction (ED) in women with preeclampsia and with the development of retinal vein occlusions. Material and Methods. The main group was formed by 62 pregnant women with preeclampsia (124 eyes). Their age ranged from 22 to 43 years (30±6.9 years). The 1st comparison group was formed by 20 women with a physiological course of pregnancy, a comparable age and duration of pregnancy. The 2nd comparison group included 16 non-pregnant women with occlusions of the superior temporal branches of the central retinal vein (16 eyes). As a control group, 20 somatically healthy, non-pregnant women (40 eyes) were selected. Markers of ED were studied twice in the main and 1st comparison groups (III trimester of pregnancy and 6-8 months after delivery). In the control and 2nd comparison groups — once. Results. The levels of von Willebrand factor and endothe-lin-1, which are known to be the main markers of ED development, turned out to be high in women of the main group (109.3±33.2% and 2.69±1.49 ng/ml respectively), and in the 2nd comparison group (110.3±29.2% and 2.6±0.4 ng/ml respectively). Conclusion. Increased endothelin-1 in the tear fluid and von Willebrand factor in blood plasma in women with preeclampsia, as well as maintaining their high levels after 6-8 months, after childbirth may indicate the presence of generalized ED, which is a favorable background for the development of vascular retinal pathology in the remote postpartum period.
Bibliography:
1. Moshetova LK, Yarovaya GA, Tsikhonchuk TV, et al. Changes in hemostasis-related parameters of blood and lacrimal fluid in patients with retinal vein occlusion. Russian Annals of Ophthalmology 2016; 132 (4): 88-93.
2. Libman ES, Shakhova EV. The state and dynamics of blindness and disability due to pathology of the organ of vision in Russia. Actual Issues of Ophthalmology 2007; (2): 12-9.
3. Cugati S, Wang JJ, Knudtson MD, et al. Retinal vein occlusion and vascular mortality. Ophthalmology 2007; 114 (3): 520-4. DOI: 10.1016/j. ophtha. 2006.06.061.
4. Rogers SL, Mclntosh RL, Lim L, et al. Natural history of branch retinal vein occlusion: an evidence-based systematic review. Ophthalmology 2010; 117(6): 1094-101. DOI: 10.1016/j. ophtha. 2010.01.058.
5. Rykov SA, Suk SA, Romanova ТА, Venediktova OA. Distribution of retinal vein occlusion in the structure of laser retinal surgery. Tavricheskiy meditsinsko-biologicheskiy vestnik 2012; 15 (3): 164-9.
6. Klein R, Klein BE, Moss SE, MeuerSM. The epidemiology of retinal vein occlusion: The Beaver Dam Eye Study. Archives of Ophthalmology 2008; 126: 513-8.
7. Kolenko OV, Sorokin EL, Khodzhaen NS, et al. The state of indicators of the angio-OCT of the macular area in pregnant women with preeclampsia in conjunction with the content of the factor of endothelial dysfunction, their importance for predicting vascular retinal pathology in the postpartum period. Fyodorov Journal of Ophthalmic Surgery 2019; (3): 63-71.
8. Sokolov El, Grishina Tl, Shtin SR. Effect of von Willebrand factor and endothelin-1 on formation of thrombotic status in patients with ischemic heart disease. Kardiologiia 2013; (3): 25-30.
9. Lopes van Balen VA, Spaan JJ, Lopes van Balen VA, et al. Prevalence of chronic kidney disease after preeclampsia. Journal of Nephrology 2017; 30 (3): 403-9. DOI: 10.1007/S40620-016-0342-1.
10. Montoro-Garcia S, Shantsila E, Lip GYH. Potential value of targeting von Willebrand factor in atherosclerotic cardiovascular disease. Expert opinion on therapeutic targets 2014; 18 (1): 43-53. DOI: 10.1517/14728222.2013.840585.
11. Sidorova IS, Nikitina NA. Pathogenesis of endotheliosis in preeclampsia. Obstetrics and Gynecology 2015; (1): 72-8
12. Bokslag A, Teunissen PW, Franssen С, et al. Effect of earlyonset preeclampsia on cardiovascular risk in the fifth decade of life. Am J Obstet Gynecol 2017; 216 (5): 523. e1 -523. e7. DOI: 10.1016/j. ajog. 2017.02.015.
13. White WM, Mielke MM, Araoz PA, et al. A history of preeclampsia is associated with a risk for coronary artery calcification 3 decades later. Am J Obstet Gynecol 2016; 214 (4): 519. e1-519. e8. DOI: 10.1016/j. ajog. 2016.02.003.
14. Kolenko OV, Sorokin EL, Khodzhaev NS, et al. Regularities of macular blood flow in pregnant women with preeclampsia in the III trimester and after delivery, risk factors for development of vascular pathology of posterior segment of the eye. Pacific Medical Journal 2019; (2): 25-8.
15. Sorokin EL, Kolenko OV, Khodzhaev NS, et al. The choroidal blood flow of eye during pregnancy and in postnatal period in women with preeclampsia, clinical part for predicting risk of vascular pathology of posterior segment of the eye. Pacific Medical Journal 2019; (2): 43-6.
| Attachment | Size |
|---|---|
| 2020_02-1_668-671.pdf | 328.13 KB |
Русский
English